| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

From the Department of Surgery,* University of Cincinnati College of Medicine, Cincinnati, Ohio; and the Division of Rheumatology,
University Hospital of Geneva, Geneva, Switzerland
Hepatic ischemia/reperfusion injury is caused primarily by the products of neutrophils recruited into the liver after reperfusion. The mediators responsible for the development of this inflammatory response are thought to be tumor necrosis factor-
and interleukin (IL)-1. Although there is abundant evidence to support a role for tumor necrosis factor-
, much less is known about the function of IL-1 in this injury. In the present studies, we investigated whether IL-1 was a critical mediator for the induction of liver inflammation after ischemia/reperfusion. Wild-type and IL-1 receptor I-knockout (IL-1RI-/-) mice were exposed to 90 minutes of partial hepatic ischemia and up to 24 hours of reperfusion. In wild-type mice, IL-1ß expression was maximal after ischemia and 8 hours of reperfusion. At the same time, both wild-type and IL-1RI-/- mice had severe liver injury as assessed by serum alanine aminotransferase levels and hepatic histopathology. However, IL-1RI-/- mice had significantly less neutrophil accumulation in liver tissues as measured by liver myeloperoxidase content and histology. The reduction in hepatic neutrophil recruitment in IL-1RI-/- mice was associated with decreased activation of the transcription factor, nuclear factor-
B, and reduced expression of the CXC chemokine, macrophage inflammatory protein-2. These data suggest that IL-1 functions to augment neutrophil accumulation, but does not play an essential role in this response.
This article has been cited by other articles:
![]() |
B. Vollmar and M. D. Menger The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and Repair Physiol Rev, October 1, 2009; 89(4): 1269 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yang, S. Hu, J. Chen, M. A. Choudhry, L. W. Rue III, K. I. Bland, and I. H. Chaudry Mechanism of hepatoprotection in proestrus female rats following trauma-hemorrhage: heme oxygenase-1-derived normalization of hepatic inflammatory responses J. Leukoc. Biol., June 1, 2009; 85(6): 1015 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kuboki, N. Sakai, J. Tschop, M. J. Edwards, A. B. Lentsch, and C. C. Caldwell Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury Am J Physiol Gastrointest Liver Physiol, May 1, 2009; 296(5): G1054 - G1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bujak, M. Dobaczewski, K. Chatila, L. H. Mendoza, N. Li, A. Reddy, and N. G. Frangogiannis Interleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac Remodeling Am. J. Pathol., July 1, 2008; 173(1): 57 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Johnston, J. P. Mizgerd, L. Flynt, L. J. Quinton, E. S. Williams, and S. A. Shore Type I Interleukin-1 Receptor Is Required for Pulmonary Responses to Subacute Ozone Exposure in Mice Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 477 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Schmitz, M. Kurrer, M. F. Bachmann, and M. Kopf Interleukin-1 Is Responsible for Acute Lung Immunopathology but Increases Survival of Respiratory Influenza Virus Infection J. Virol., May 15, 2005; 79(10): 6441 - 6448. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Dorman, J. S. Gujral, M. L. Bajt, A. Farhood, and H. Jaeschke Generation and functional significance of CXC chemokines for neutrophil-induced liver injury during endotoxemia Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G880 - G886. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Matzer, F. Rodel, R. M. Strieter, M. Rollinghoff, and H. U. Beuscher Constitutive expression of CXCL2/MIP-2 is restricted to a Gr-1high, CD11b+, CD62Lhigh subset of bone marrow derived granulocytes Int. Immunol., November 1, 2004; 16(11): 1675 - 1683. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |